$ONCO News

Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement

Onconetix Announces Reverse Stock Split

Onconetix Announces 1-For-10 Reverse Stock Split Effective On November 6, 2026

Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition

Realbotix Announces Additional Draw under Bridge Loan from Onconetix

Onconetix Makes Additional Advance Of $500K To Realbotix Under Strategic Bridge Financing Facility

CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition

Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition

Realbotix LLC Announces Bridge Loan from Onconetix

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG

Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation

Onconetix Highlights Realbotix’s Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District

Oncopeptides Announces First Patient Enrollment In Clinical "Window-Of-Opportunity" Study Evaluating Proprietary Peptide Drug Conjugate Platform In Glioblastoma

Onconetix, Inc. Announces 1-for-10 Reverse Stock Split

UPDATED: Onconetix Announces 1-For-10 Reverse Stock Split, Effective May 21, 2026

Onconetix (ONCO) Stock Surges Over 23% Overnight: Why Is It Moving?

Onconetix Q1 EPS $(6.71) Up From $(225.25) YoY, Sales $21.457K Down From $101.630K YoY

Onconetix Andrew Oakley Resigns As Chairman Of Board; Co. Appoints Sammy Dorf As Chairman Of The Board Effective April 23, 2026

Onconetix Stock Skyrockets After Realbotix Ships Vinci-Equipped Robot To Ericsson

Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson